Table 1.
Compound | hHSD1 IC50 (nM) | HEK hHSD2 % inh 10 µM or IC50 c | HLM % Parent d | mHSD1 IC50 (nM) | MLM % Parent d |
---|---|---|---|---|---|
1 | 86 | 88% | 74 | ND | ND |
2 | 19 | 1–10 µM | 27 | ND | ND |
3 | 29 | 0.1–1 µM | 94 | 81 | 93 |
a See Experimental section for further details; b Percentage inhibition was determined relative to a no inhibitor control; c HEK293 cells stably transfected with the full-length gene coding for human 11β-HSD2 were used; d The microsomal stability of each compound was determined using either human or mouse liver microsomes (HLM or MLM).